www.fdanews.com/articles/183915-washington-state-compounder-used-unapproved-ingredients-fda-says
Washington State Compounder Used Unapproved Ingredients, FDA Says
October 11, 2017
A Washington state pharmacy used ingredients that are not covered by a designated monograph in compounding drugs, meaning it lost its exemption for labeling requirements, and also failed to maintain sanitary conditions for drug production, the FDA said in a warning letter.
Without the labeling exemption, the compounder — Riverpoint Pharmacy, of Spokane — landed in hot water as a producer of misbranded drugs, the FDA said.
FDA rules for sanitary production apply with or without the exemption, and Riverpoint also violated those rules, the agency said.